North America Urology Devices Market (2025-2030)
The North America Urology Devices Market was valued at $6223.5 Million in 2025 and projected to reach to $7817.4 Million by 2030, representing a compound annual growth rate of 4.7%. The North American urology devices market is positioned for consistent growth through 2030, driven by an aging population with rising incidence of benign prostatic hyperplasia, urinary incontinence, and kidney stone disease.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Urology Devices Market Trends and Insights
- North America maintains a significant share of the global urology devices market, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong reimbursement frameworks across the United States and Canada.
- The region benefits from established diagnostic and therapeutic capabilities, with North America leading in innovation and clinical adoption of next-generation urological technologies. Growth in North America's urology devices market is supported by an aging population, rising prevalence of urological conditions including benign prostatic hyperplasia and urinary incontinence, and increasing patient awareness.
- North America's regulatory environment, particularly FDA approval pathways, accelerates market entry for novel devices.
- The competitive landscape in North America remains robust, with both established medical device manufacturers and emerging players investing in product development and market expansion throughout the 2025–2030 forecast period..
Key Market Statistics
- CAGR (2025-2030) 4.7% CAGR
- Market Size, 2025 ~USD 6223.5 Million
- Forecast, 2030 ~USD 7817.4 Million
- Geography North America
North America Urology Devices Market Overview
Market Leadership Position :
North America commands a substantial share of the global urology devices market, supported by cutting-edge healthcare infrastructure, high patient awareness, and robust clinical adoption rates across major metropolitan areas.
Minimally Invasive Procedure Dominance :
The region demonstrates exceptional uptake of minimally invasive urological procedures, driven by surgeon expertise, patient preference for reduced recovery times, and strong hospital investment in advanced endoscopic and laser technologies.
Reimbursement Framework Strength :
Comprehensive insurance coverage and favorable reimbursement policies from Medicare, Medicaid, and private insurers in the US and Canada accelerate device adoption and support sustained market expansion through 2030.
Steady Growth Trajectory :
With a projected CAGR of 4.7% from 2025 to 2030, the North American market is expected to expand from $6,223.5 million to $7,817.4 million, reflecting aging demographics and increasing prevalence of urological conditions.
North America Urology Devices Market Dynamics
- Advanced reimbursement structures and high healthcare spending per capita support continued investment in innovative technologies including robotic-assisted systems, laser lithotripsy devices, and urodynamic equipment. Key growth catalysts include expanding minimally invasive procedure adoption, increasing outpatient surgical center utilization, and growing demand for home-based diagnostic solutions.
- The region's strong regulatory environment and emphasis on clinical evidence ensure rapid commercialization of breakthrough devices, while competitive pricing pressures and consolidation among device manufacturers will shape market dynamics through the forecast period..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America's urology devices market is valued at $6,223.5 million in 2025 and will reach $7,817.4 million by 2030, representing a 4.7% CAGR.
- North America leads in adoption of minimally invasive urological procedures, supported by advanced healthcare infrastructure and strong reimbursement policies.
- An aging population and rising prevalence of urological conditions drive sustained demand for diagnostic and therapeutic devices across North America.
- North America's favorable regulatory environment and innovation ecosystem position the region as a key market for emerging urological device technologies.
Urology Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | URINARY INCONTINENCE (UI) (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 34.57 (2025) |
| Revenue Forecast (Billions) | ~USD 46.26 (2030) |
| Segments Covered | Product, Type, Application, End User |
North America Urology Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables & Accessories
- Instruments
By Type
- Biopsy Devices
- Catheters
- Cystoscopes
- Dialysis Consumables
- Dialysis Devices
- Dilator Sets & Urethral Access Sheaths
- Drainage Bags
- Endoscopes
- Endoscopy Fluid Management Systems
- Endovision & Imaging Systems
- External Catheters
- Guidewires
- Hemodialysis Devices
- Indwelling/ Foley Catheters
- Insufflators
- Intermittent Catheters
- Laparoscopes
- Laser & Lithotripsy Devices
- Nephroscopes
- Other Consumables & Accessories
- Other Instruments
- Peritoneal Dialysis Devices
- Resectoscopes
- Retrieval Devices & Extractors
- Robotic Systems
- Stents And Implants
- Surgical Dissectors, Forceps & Needle Holders
- Tubes & Distal Attachments
- Ureteroscopes
- Urodynamic Systems
By Application
- Benign Prostatic Hyperplasia (Bph)
- Erectile Dysfunction
- Kidney Diseases
- Other Applications
- Pelvic Organ Prolapse
- Urinary Incontinence (Ui)
- Urinary Stones
- Urological Cancer
By End User
- Ambulatory Surgery Centers
- Clinics
- Dialysis Centers
- Home Care Settings
- Hospitals
Target Audience
- Medical Device Manufacturers : Develop go-to-market strategies, assess competitive positioning, and identify white-space opportunities in the North American urology devices market with country-specific insights.
- Healthcare Investors & PE Firms : Evaluate investment opportunities in urology device companies and healthcare providers with detailed North American market sizing, growth forecasts, and profitability drivers.
- Hospital & Surgical Center Administrators : Make informed capital equipment purchasing decisions and budget allocation for urology departments based on market trends, technology adoption rates, and reimbursement landscape.
- Regulatory & Compliance Consultants : Navigate FDA, Health Canada, and provincial regulatory requirements with market context on device approval timelines, reimbursement pathways, and competitive dynamics in North America.
- Market Research & Strategy Teams : Support corporate strategy, business development, and market planning initiatives with comprehensive North American urology devices market data and forward-looking forecasts.
Key Companies in the North America Urology Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| SIEMENS HEALTHINEERS | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| NOVANTA, INC | United States | Public Company | Precision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration), |
| LUMENIS LTD | Israel | Private Company | Surgical,Ophthalmic,Aesthetic, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits), |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Germany | Public Company | Care Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| B. BRAUN MELSUNGEN AG | Germany | Private Company | Infusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions, |
| CARDINAL HEALTH | United States | Public Company | Branded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services, |
| INTUITIVE SURGICAL | United States | Public Company | da Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories, |
| COLOPLAST A/S | Denmark | Public Company | Ostomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel), |
| STRYKER | United States | Public Company | Orthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures), |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Advanced Wound Care,Ostomy Care,Continence Care, |
| MEDTRONIC PLC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
SIEMENS HEALTHINEERS
Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.
NOVANTA, INC
Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.
LUMENIS LTD
Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.
MERIT MEDICAL
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.
FRESENIUS MEDICAL CARE AG & CO. KGAA
Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.
B. BRAUN MELSUNGEN AG
B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.
OLYMPUS CORPORATION
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.
CARDINAL HEALTH
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.
INTUITIVE SURGICAL
Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.
COLOPLAST A/S
Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.
STRYKER
Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.
TELEFLEX INCORPORATED
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.
CONVATEC GROUP PLC
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.
MEDTRONIC PLC
Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 12796.5 Million |
| Canada | USD 2149.6 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Segmentation : Access detailed market sizing for US and Canada individually, enabling precise market entry strategies and competitive positioning within North America's distinct healthcare ecosystems.
- Reimbursement & Regulatory Insights : Understand Medicare/Medicaid coverage policies, FDA approval pathways, and provincial health authority requirements that directly impact device commercialization timelines and market penetration rates.
- Competitive Landscape Analysis : Identify leading device manufacturers, market share distribution, and emerging competitors in North America's urology sector to inform partnership and acquisition strategies.
- Growth Driver Identification : Quantify the impact of aging demographics, procedure volume trends, and technology adoption rates specific to North American healthcare systems on future market expansion.
- Investment Decision Support : Leverage 5-year forecast data and regional growth projections to validate business cases, allocate R&D budgets, and prioritize market expansion initiatives in high-opportunity segments.
Frequently asked questions
What is the current size of the North America urology devices market?
The North America urology devices market is valued at $6,223.5 million in 2025 and is expected to grow to $7,817.4 million by 2030.
What is the projected growth rate for North America's urology devices market?
North America's urology devices market is projected to grow at a CAGR of 4.7% from 2025 to 2030.
What factors are driving growth in North America's urology devices market?
Key growth drivers in North America include an aging population, rising prevalence of urological conditions, high adoption of minimally invasive procedures, strong reimbursement frameworks, and advanced healthcare infrastructure.
How does North America's urology devices market compare to other regions?
North America maintains a significant global market share, characterized by advanced healthcare systems, strong regulatory frameworks, high innovation rates, and early adoption of new urological technologies compared to other regions.
What regulatory factors influence the North America urology devices market?
North America's FDA approval pathways, stringent quality standards, and favorable reimbursement policies create a supportive environment for device innovation and market entry, accelerating the introduction of novel urological technologies.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Urology Devices Market : Top-Down and Bottom-Up Approach
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.
Key Stakeholders
- Manufacturers and Distributors of Urology Devices
- Hospitals and ASCs
- Academic Research Institutes
- Urology Clinics
- Urology Device Service Providers
- Venture Capitalists and Investors
- Clinical Research Organizations (CROs)
Report Objectives
- To define, describe, and forecast the urology devices market by product, application, end user, and region
- To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
- To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market
Customization Options
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix gives a detailed comparison of the product portfolios of the top five companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographical Analysis
- A further breakdown of the Rest of Europe’s urology devices market into countries
- A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
- A further breakdown of Latin America’s urology devices market into countries
Get the Full Urology Devices Market Report
Full forecast, segment splits, and company analysis for all Urology Devices Market.
- US Urology Devices Market
- Canada Urology Devices Market
- Germany Urology Devices Market
- UK Urology Devices Market
- France Urology Devices Market
- Italy Urology Devices Market
- Spain Urology Devices Market
- China Urology Devices Market
- Japan Urology Devices Market
- India Urology Devices Market
- Brazil Urology Devices Market
- Mexico Urology Devices Market
- Rest Of Europe Urology Devices Market
- Rest Of Asia Pacific Urology Devices Market
- Rest Of Latin America Urology Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report